End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
49.73 CNY | +0.18% | -11.75% | -9.53% |
Mar. 29 | Tigermed Consulting's Profit, Revenue Climb in 2023 | MT |
Mar. 28 | Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.53% | 5.56B | |
+2.05% | 42.11B | |
+48.94% | 40.08B | |
+7.58% | 40B | |
-10.82% | 26.87B | |
+7.07% | 24.58B | |
-22.16% | 18.44B | |
+1.47% | 11.94B | |
+29.66% | 11.66B | |
+7.67% | 11.01B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- LTZ Therapeutics announced that it has received $17 million in funding from K2VC, Qiming Weichuang Venture Capital Management Company Limited, Hangzhou Tigermed Consulting Co., Ltd